Cerenis Therapeutics – pharmaceutical daily

April 9, 2019 Off

Cerevel Therapeutics Announces Publication of Phase 2a Study Results in Neurology on Its Most Advanced Investigational Epilepsy Treatment

Findings Demonstrate Promising Anticonvulsant Activity with CVL-865, a Novel Selective GABA Potentiator, in Patients with Photosensitive Epilepsy Company to Initiate…

January 20, 2017 Off

Cerenis satisfied with Q4 2016, expects good news from clinic in Q1 2017

By Dino Mustafić

French company Cerenis Therapeutics has seen some good things happen in the previous period in clinics by finalizing certain studies and getting FDA’s approval to kick some off. Also certain results showed progress and the company has reported solid cash position for the end of the year.

December 16, 2016 Off

FDA OK’s Cerenis’s CER-209 clinical trial for liver disease treatment

By Dino Mustafić

U.S. Food and Drug Administration (FDA) has given green light to Cerenis Therapeutics to proceed with CER-209 clinical trial.